Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease

Clinical Research in Cardiology

Volumn 99, Issue 12, 2010, Pages 787-794

  Zankl, A R ^a   Ivandic, B ^a   Andrassy, M ^a   Volz, H C ^a   Krumsdorf, U ^a   Blessing, E ^a   Katus, H A ^a   Tiefenbacher, C P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin receptor blockade; Atherosclerosis; Endothelial dysfunction; Peripheral artery disease

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; TELMISARTAN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; ENDOTHELIUM; FEMALE; HUMAN; HYPERTENSION; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREADMILL EXERCISE; VASODILATATION; WALKING;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANKLE BRACHIAL INDEX; BENZIMIDAZOLES; BENZOATES; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VASODILATION; WALKING;

EID: 78649673294     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0184-0     Document Type: Article

References (32)

1. AM O'Hare R Katz MG Shlipak M Cushman AB Newman 2006 Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study Circulation 113 388 393 10.1161/CIRCULATIONAHA.105. 570903 16432070 (Pubitemid 43803200)
2. CP Tiefenbacher T Bleeke C Vahl K Amann A Vogt W Kubler 2000 Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis Circulation 102 2172 2179 1:CAS:528:DC%2BD3cXptVSjtbc%3D 11056088
3. O Yiginer F Ozcelik T Inanc M Aparci N Ozmen BY Cingozbay E Kardesoglu S Suleymanoglu G Sener BS Cebeci 2008 Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome Clin Res Cardiol 97 334 340 1:CAS:528:DC%2BD1cXmvVCltbk%3D 10.1007/s00392-007- 0636-3 18330493
4. A Daiber P Wenzel M Oelze T Munzel 2008 New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance Clin Res Cardiol 97 12 20 1:CAS:528:DC%2BD1cXisVyisLk%3D 10.1007/s00392-007-0588-7 17938848
5. H Mollnau M Wendt K Szocs B Lassegue E Schulz M Oelze H Li M Bodenschatz M August AL Kleschyov N Tsilimingas U Walter U Forstermann T Meinertz K Griendling T Munzel 2002 Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling Circ Res 90 E58 E65 10.1161/01.RES.0000012569.55432.02 11884382
6. Y Higashi S Sasaki K Nakagawa T Ueda A Yoshimizu S Kurisu H Matsuura G Kajiyama T Oshima 2000 A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study J Am Coll Cardiol 35 284 291 1:CAS:528:DC%2BD3cXhs1elsL4%3D 10.1016/S0735-1097(99)00561-6 10676671 (Pubitemid 30125515)
7. GB Mancini GC Henry C Macaya BJ O'Neill AL Pucillo RG Carere TJ Wargovich H Mudra TF Luscher MI Klibaner HE Haber AC Uprichard CJ Pepine B Pitt 1996 Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study Circulation 94 258 265 1:CAS:528:DyaK28XltF2rsro%3D 8759064
8. RE Schmieder J Schrader W Zidek U Tebbe WD Paar P Bramlage D Pittrow M Bohm 2007 Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 96 247 257 1:CAS:528:DC%2BD2sXms1Sku7c%3D 10.1007/s00392-007- 0510-3 17453140 (Pubitemid 46740083)
9. S Morimoto Y Yano K Maki K Sawada 2006 Renal and vascular protective effects of telmisartan in patients with essential hypertension Hypertens Res 29 567 572 1:CAS:528:DC%2BD28XhtFOrtrbP 10.1291/hypres.29.567 17137211 (Pubitemid 44437358)
10. RE Schmieder C Delles A Mimran JP Fauvel LM Ruilope 2007 Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes Diabetes Care 30 1351 1356 1:CAS:528: DC%2BD2sXntlWksLs%3D 10.2337/dc06-1551 17337492 (Pubitemid 46871137)
11. JE Deanfield JP Halcox TJ Rabelink 2007 Endothelial function and dysfunction: testing and clinical relevance Circulation 115 1285 1295 17353456
12. R Joannides WE Haefeli L Linder V Richard EH Bakkali C Thuillez TF Luscher 1995 Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo Circulation 91 1314 1319 1:CAS:528:DyaK2MXkvF2ks74%3D 7867167
13. J Deanfield A Donald C Ferri C Giannattasio J Halcox S Halligan A Lerman G Mancia JJ Oliver AC Pessina D Rizzoni GP Rossi A Salvetti EL Schiffrin S Taddei DJ Webb 2005 Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension J Hypertens 23 7 17 1:CAS:528:DC%2BD2MXitVCjsQ%3D%3D 10.1097/00004872-200501000-00004 15643116 (Pubitemid 40128972)
14. FG Fowkes 1988 The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys Int J Epidemiol 17 248 254 1:STN:280:DyaL1c3psl2lug%3D%3D 10.1093/ije/17.2.248 3042648
15. PJ Osmundson WM O'Fallon IP Clements FJ Kazmier BR Zimmerman PJ Palumbo 1985 Reproducibility of noninvasive tests of peripheral occlusive arterial disease J Vasc Surg 2 678 683 1:STN:280:DyaL2M3ptlertw%3D%3D 10.1067/mva.1985.avs0020678 4032606 (Pubitemid 16240237)
16. L Norgren WR Hiatt JA Dormandy MR Nehler KA Harris FG Fowkes 2007 Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl S S5 S67 10.1016/j.jvs.2006.12.037 17223489 (Pubitemid 46151680)
17. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M (2007) Mannheim carotid IMT consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23:75-80
18. M Bullinger M Cachovan A Creutzig C Diehm J Gruss H Heidrich I Kirchberger H Loeprecht W Rogatti 1996 Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire) Vasa 25 32 40 1:STN:280:DyaK2s%2Fgtl2msA%3D%3D 8851263
19. RA Benndorf D Appel R Maas E Schwedhelm UO Wenzel RH Boger 2007 Telmisartan improves endothelial function in patients with essential hypertension J Cardiovasc Pharmacol 50 367 371 1:CAS:528:DC%2BD2sXht1ygtb3J 10.1097/FJC.0b013e31811dfbe7 18049303
20. S Wassmann S Hilgers U Laufs M Bohm G Nickenig 2002 Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction Arterioscler Thromb Vasc Biol 22 1208 1212 1:CAS:528: DC%2BD38XlsFWgtrg%3D 10.1161/01.ATV.0000022847.38083.B6 12117739 (Pubitemid 34764875)
21. A Warnholtz MA Ostad T Heitzer F Thuneke M Frohlich P Tschentscher E Schwedhelm R Boger T Meinertz T Munzel 2007 AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease Atherosclerosis 194 439 445 1:CAS:528:DC%2BD2sXhtFerurbJ 10.1016/j.atherosclerosis.2006.08.034 16970950 (Pubitemid 47513075)
22. MG Modena L Bonetti F Coppi F Bursi R Rossi 2002 Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women J Am Coll Cardiol 40 505 510 10.1016/S0735-1097(02)01976-9 12142118 (Pubitemid 34833167)
23. H Sasamura Y Kitamura M Nakamura M Ryuzaki T Saruta 2006 Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension Clin Exp Hypertens 28 511 520 1:CAS:528:DC%2BD28Xot1Gru78%3D 10.1080/10641960600798721 16820347 (Pubitemid 44034675)
24. C Schindler A Mueller P Bramlage W Boecking W Kirch J Schweizer 2007 Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study Angiology 58 710 716 1:CAS:528:DC%2BD1cXhtlems7Y%3D 10.1177/0003319707305962 17928625
25. I Petrovic D Petrovic N Vukovic B Zivanovic J Dragicevic Z Vasiljevic R Babic 2005 Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients J Int Med Res 33 Suppl 1 39A 49A 1:CAS:528:DC%2BD2MXhtFequ7jL 16222899
26. B Ariff A Zambanini S Vamadeva D Barratt Y Xu P Sever A Stanton A Hughes S Thom 2006 Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension Stroke 37 2381 2384 1:CAS:528:DC%2BD28Xotlaisrc%3D 10.1161/01.STR.0000236839.69658.c5 16888272 (Pubitemid 44337189)
27. A Ichihara Y Kaneshiro T Takemitsu M Sakoda H Itoh 2006 Benefits of candesartan on arterial and renal damage of non-diabetic hypertensive patients treated with calcium channel blockers Am J Nephrol 26 462 468 1:CAS:528:DC%2BD28XhtlWnur%2FL 10.1159/000096581 17063001 (Pubitemid 44971737)
28. DH O'Leary JF Polak RA Kronmal TA Manolio GL Burke SK Wolfson Jr 1999 Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 14 22 10.1056/NEJM199901073400103 9878640 (Pubitemid 29024679)
29. JR Menard HE Smith D Riebe CM Braun B Blissmer RB Patterson 2004 Long-term results of peripheral arterial disease rehabilitation J Vasc Surg 39 1186 1192 10.1016/j.jvs.2004.01.034 15192556 (Pubitemid 38952584)
30. LJ Ruger D Irnich TN Abahji A Crispin U Hoffmann PM Lang 2008 Characteristics of chronic ischemic pain in patients with peripheral arterial disease Pain 139 201 208 10.1016/j.pain.2008.03.027 18472216
31. S Yusuf KK Teo J Pogue L Dyal I Copland H Schumacher G Dagenais P Sleight C Anderson 2008 Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 1547 1559 1:CAS:528:DC%2BD1cXksF2isLs%3D 10.1056/NEJMoa0801317 18378520 (Pubitemid 351522739)
32. TJ Anderson A Uehata MD Gerhard IT Meredith S Knab D Delagrange EH Lieberman P Ganz MA Creager AC Yeung, et al. 1995 Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 26 1235 1241 1:STN:280:DyaK28%2Fjtlykug%3D%3D 10.1016/0735-1097(95)00327-4 7594037